# A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components

> **NCT03562624** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 177 (actual)

## Conditions studied

- Contraception

## Interventions

- **DRUG:** BAY98-7443
- **DRUG:** Levonogestrel (Skyla, BAY86-5028)

## Key facts

- **NCT ID:** NCT03562624
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-22
- **Primary completion:** 2019-05-16
- **Final completion:** 2019-08-01
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2019-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03562624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03562624, "A Study to Compare 3 Doses of a Hormonal Intra-uterine Device Containing Levonorgestrel and Indomethacin With a Hormonal Intra-uterine Device Containing Only Levonorgestrel to Assess the Effect and Safety of the Combined Components". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03562624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*